Melatonin vs. placebo for the symptoms of delirium in elderly medical inpatients

Phase 2

Completed

• Conditions: delirium; Neurological - Other neurological disorders

• Registration Number: ACTRN12614000101684
• Lead Sponsor: The Royal Melbourne Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-01-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

Diagnosis of delirium (regardless of cause)
Inpatient under general medicine of the The Royal Melbourne Hospital

Exclusion Criteria

Exclusively hypoactive delirium, recent stroke (<14 days), sensory impairment or dysphasia or language such that not evaluable, undergoing surgery, prognosis <7days, severe hepatic or renal failure, allergy or intolerance to melatonin or excipients.

Study & Design

• Study Type: Interventional
• Study Design: Not specified